The FDA has provided clearance for Siemens SOMATOM portfolio of CT scanners for low-dose lung cancer screening.
The U.S. FDA has cleared the SOMATOM CT systems by Siemens Healthcare for low-dose lung cancer screening, Siemens announced last week.
All of Siemens new CT scanners, as well as the company’s installed base of non-end-of-support systems use standard low-dose lung protocols already delivered on the scanners, Siemens said in a release. Automated settings in the Siemens’ portfolio, like reducing user variability, and setting an optimum range for scan settings that avoids cut-offs or excessive radiation, optimize the low-dose lung cancer screening workflow, Siemens said.
Siemens has also launched a mobile imaging solution for lung cancer screening aimed for people living in rural areas, the company announced. The mobile SOMATOM Scope CT is a self-powered mobile CT with an on-board diesel generator that is ready to scan “within minutes” of parking and is equipped with a high-speed wireless connection, Siemens said.
The indication for low-dose lung cancer screening is available for the following CT systems: SOMATOM Force, SOMATOM Definition Flash, SOMATOM Definition Edge, SOMATOM Definition AS/AS+, SOMATOM Perspective, SOMATOM Scope, and the SOMATOM Emotion 16.
[[{"type":"media","view_mode":"media_crop","fid":"43954","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_4646017352372","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"4885","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right;","title":"Image provided courtesy of Siemens Healthcare.","typeof":"foaf:Image"}}]]
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
Can Intestinal Ultrasound Provide an Alternative for Evaluating Creeping Fat with Crohn’s Disease?
September 25th 2024Intestinal ultrasound demonstrated an 88.2 percent agreement with computed tomography enterography in characterizing creeping fat in patients with Crohn’s disease, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.